Lack of agents directly targeting SCN1A dysfunction/Nav1.1 channelopathy: No current drug corrects the impaired GABAergic interneuron function caused by NaV1.1 channel deficits (de Lange et al., 2018; Wallace et al., 2016; Schoonjans, 2019). The gene discussed is SCN1A; the disease is channelopathy.